Amgen's Blincyto Data Send Cullinan Higher
WHO Picks JN.1 Variant for Next Set of COVID Vaccines
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.